{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:33:05Z","timestamp":1793871185691,"version":"4.6.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Univ of WA Dept of Lab Medicine\/Pathology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-33082-8","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T20:04:55Z","timestamp":1766347495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cellular heterogeneity and therapeutic response profiling of human IDH\u2009+\u2009glioma stem cell cultures"],"prefix":"10.1038","volume":"16","author":[{"given":"Nyasha","family":"Chambwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan F.","family":"Kohrn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlo","family":"Lazarchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Leutert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangrong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahar","family":"Tercan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Sanchez-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiliang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome J.","family":"Graber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Paddison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Vill\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Shmulevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Raymond J.","family":"Monnat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"key":"33082_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","volume":"10","author":"M Weller","year":"2024","unstructured":"Weller, M. et al. Glioma. Nat. Rev. Dis. Primers 10, 33 (2024).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"33082_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1101\/gad.324301.119","volume":"33","author":"RC Gimple","year":"2019","unstructured":"Gimple, R. C., Bhargava, S., Dixit, D. & Rich, J. N. Glioblastoma stem cells: Lessons from the tumor hierarchy in a lethal cancer. Genes Dev. 33, 591\u2013609 (2019).","journal-title":"Genes Dev."},{"key":"33082_CR3","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.ccell.2020.04.001","volume":"37","author":"ML Suv\u00e0","year":"2020","unstructured":"Suv\u00e0, M. L. & Tirosh, I. The glioma stem cell model in the era of single-cell genomics. Cancer Cell 37, 630\u2013636 (2020).","journal-title":"Cancer Cell"},{"key":"33082_CR4","doi-asserted-by":"publisher","first-page":"050533","DOI":"10.1242\/dmm.050533","volume":"17","author":"FB Furnari","year":"2024","unstructured":"Furnari, F. B. et al. Stem cell modeling of nervous system tumors. Dis. Model. Mech. 17, 050533 (2024).","journal-title":"Dis. Model. Mech."},{"key":"33082_CR5","doi-asserted-by":"publisher","first-page":"e20220808","DOI":"10.1084\/jem.20220808","volume":"222","author":"SM Cirigliano","year":"2025","unstructured":"Cirigliano, S. M. & Fine, H. A. Bridging the gap between tumor and disease: Innovating cancer and glioma models. J. Exp. Med. 222, e20220808 (2025).","journal-title":"J. Exp. Med."},{"key":"33082_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/neuonc\/noae064.233","volume":"26","author":"M Price","year":"2024","unstructured":"Price, M. et al. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2017\u20132021. Neuro Oncol. 26, 1\u201385 (2024).","journal-title":"Neuro Oncol."},{"key":"33082_CR7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.stem.2009.03.003","volume":"4","author":"MJ Son","year":"2009","unstructured":"Son, M. J., Woolard, K., Nam, D.-H., Lee, J. & Fine, H. A. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 4, 440\u2013452 (2009).","journal-title":"Cell Stem Cell"},{"key":"33082_CR8","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1158\/0008-5472.CAN-08-3886","volume":"69","author":"H Wakimoto","year":"2009","unstructured":"Wakimoto, H. et al. Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res. 69, 3472\u20133481 (2009).","journal-title":"Cancer Res."},{"key":"33082_CR9","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1016\/j.celrep.2015.11.021","volume":"13","author":"CM Toledo","year":"2015","unstructured":"Toledo, C. M. et al. Genome-wide CRISPR-Cas9 screens reveal loss of redundancy between PKMYT1 and WEE1 in glioblastoma stem-like cells. Cell Rep. 13, 2425\u20132439 (2015).","journal-title":"Cell Rep."},{"key":"33082_CR10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987\u2013996 (2005).","journal-title":"N. Engl. J. Med."},{"key":"33082_CR11","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi, M. E. et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352, 997\u20131003 (2005).","journal-title":"N. Engl. J. Med."},{"key":"33082_CR12","first-page":"165","volume":"3","author":"EA Horne","year":"2021","unstructured":"Horne, E. A. et al. A brain-penetrant microtubule-targeting agent that disrupts hallmarks of glioma tumorigenesis. Neurooncol. Adv. 3, 165 (2021).","journal-title":"Neurooncol. Adv."},{"key":"33082_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/s12967-024-05234-3","volume":"22","author":"JJ Vicente","year":"2024","unstructured":"Vicente, J. J. et al. The microtubule targeting agent ST-401 triggers cell death in interphase and prevents the formation of polyploid giant cancer cells. J. Transl. Med. 22, 441 (2024).","journal-title":"J. Transl. Med."},{"key":"33082_CR14","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/gcc.20690","volume":"48","author":"H-SS Dahlback","year":"2009","unstructured":"Dahlback, H.-S.S. et al. Genomic aberrations in 80 cases of primary glioblastoma multiforme: Pathogenetic heterogeneity and putative cytogenetic pathways. Genes Chromosom Cancer 48, 908\u2013924 (2009).","journal-title":"Genes Chromosom Cancer"},{"key":"33082_CR15","first-page":"405","volume":"48","author":"SH Bigner","year":"1988","unstructured":"Bigner, S. H. et al. Specific chromosomal abnormalities in malignant human gliomas. Cancer Res. 48, 405\u2013411 (1988).","journal-title":"Cancer Res."},{"key":"33082_CR16","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis, N. M. et al. REVEL: An ensemble method for predicting the pathogenicity of rare missense variants. Am. J. Hum. Genet. 99, 877\u2013885 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"33082_CR17","doi-asserted-by":"publisher","first-page":"7492","DOI":"10.1126\/science.adg7492","volume":"381","author":"J Cheng","year":"2023","unstructured":"Cheng, J. et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science 381, 7492 (2023).","journal-title":"Science"},{"key":"33082_CR18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41586-020-2209-9","volume":"580","author":"M Touat","year":"2020","unstructured":"Touat, M. et al. Mechanisms and therapeutic implications of hypermutation in gliomas. Nature 580, 517\u2013523 (2020).","journal-title":"Nature"},{"key":"33082_CR19","first-page":"105","volume":"6","author":"T Haynes","year":"2024","unstructured":"Haynes, T., Gilbert, M. R., Breen, K. & Yang, C. Pathways to hypermutation in high-grade gliomas: Mechanisms, syndromes, and opportunities for immunotherapy. Neurooncol. Adv. 6, 105 (2024).","journal-title":"Neurooncol. Adv."},{"key":"33082_CR20","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1038\/s41467-024-45979-5","volume":"15","author":"X Cheng","year":"2024","unstructured":"Cheng, X. et al. Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma. Nat. Commun. 15, 1957 (2024).","journal-title":"Nat. Commun."},{"key":"33082_CR21","first-page":"085","volume":"5","author":"TE Richardson","year":"2023","unstructured":"Richardson, T. E. et al. Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma. Neurooncol. Adv. 5, 085 (2023).","journal-title":"Neurooncol. Adv."},{"key":"33082_CR22","doi-asserted-by":"publisher","first-page":"14087","DOI":"10.1073\/pnas.1211502109","volume":"109","author":"TC Larman","year":"2012","unstructured":"Larman, T. C. et al. Spectrum of somatic mitochondrial mutations in five cancers. Proc. Natl. Acad. Sci. USA 109, 14087\u201314091 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"33082_CR23","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/neuonc\/nov020","volume":"17","author":"RE Lloyd","year":"2015","unstructured":"Lloyd, R. E. et al. Identification and functional prediction of mitochondrial complex III and IV mutations associated with glioblastoma. Neuro Oncol. 17, 942\u2013952 (2015).","journal-title":"Neuro Oncol."},{"key":"33082_CR24","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.3390\/ijms22115855","volume":"22","author":"MB Le\u00e3o Barros","year":"2021","unstructured":"Le\u00e3o Barros, M. B., Pinheiro, D. R. & Borges, B. N. Mitochondrial DNA alterations in glioblastoma (GBM). Int. J. Mol. Sci. 22, 5855 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"33082_CR25","doi-asserted-by":"publisher","first-page":"e1003794","DOI":"10.1371\/journal.pgen.1003794","volume":"9","author":"SR Kennedy","year":"2013","unstructured":"Kennedy, S. R., Salk, J. J., Schmitt, M. W. & Loeb, L. A. Ultra-sensitive sequencing reveals an age-related increase in somatic mitochondrial mutations that are inconsistent with oxidative damage. PLoS Genet. 9, e1003794 (2013).","journal-title":"PLoS Genet."},{"key":"33082_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ana.24709","volume":"80","author":"JG Hoekstra","year":"2016","unstructured":"Hoekstra, J. G., Hipp, M. J., Montine, T. J. & Kennedy, S. R. Mitochondrial DNA mutations increase in early stage Alzheimer disease and are inconsistent with oxidative damage. Ann. Neurol. 80, 301\u2013306 (2016).","journal-title":"Ann. Neurol."},{"key":"33082_CR27","doi-asserted-by":"publisher","first-page":"e1003990","DOI":"10.1371\/journal.pgen.1003990","volume":"9","author":"SL Williams","year":"2013","unstructured":"Williams, S. L., Mash, D. C., Z\u00fcchner, S. & Moraes, C. T. Somatic mtDNA mutation spectra in the aging human putamen. PLoS Genet. 9, e1003990 (2013).","journal-title":"PLoS Genet."},{"key":"33082_CR28","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel, C. et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178, 835-849.e21 (2019).","journal-title":"Cell"},{"key":"33082_CR29","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.1016\/j.neuron.2024.10.012","volume":"112","author":"XP Xie","year":"2024","unstructured":"Xie, X. P. et al. Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrence. Neuron 112, 4017-4032.e6 (2024).","journal-title":"Neuron"},{"key":"33082_CR30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"CW Brennan","year":"2013","unstructured":"Brennan, C. W. et al. The somatic genomic landscape of glioblastoma. Cell 155, 462\u2013477 (2013).","journal-title":"Cell"},{"key":"33082_CR31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ccell.2021.01.006","volume":"39","author":"L-B Wang","year":"2021","unstructured":"Wang, L.-B. et al. Proteogenomic and metabolomic characterization of human glioblastoma. Cancer Cell 39, 509-528.e20 (2021).","journal-title":"Cancer Cell"},{"key":"33082_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccell.2017.12.012","volume":"33","author":"Q Wang","year":"2018","unstructured":"Wang, Q. et al. Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell 33, 152 (2018).","journal-title":"Cancer Cell"},{"key":"33082_CR33","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.stem.2018.03.011","volume":"22","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. Reciprocal signaling between glioblastoma stem cells and differentiated tumor cells promotes malignant progression. Cell Stem Cell 22, 514-528.e5 (2018).","journal-title":"Cell Stem Cell"},{"key":"33082_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-020-02085-1","volume":"21","author":"CE Eyler","year":"2020","unstructured":"Eyler, C. E. et al. Single-cell lineage analysis reveals genetic and epigenetic interplay in glioblastoma drug resistance. Genome Biol 21, 174. https:\/\/doi.org\/10.1186\/s13059-020-02085-1 (2020).","journal-title":"Genome Biol"},{"key":"33082_CR35","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1038\/s41467-020-17139-y","volume":"11","author":"S Oh","year":"2020","unstructured":"Oh, S. et al. Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities. Nat. Commun. 11, 3288 (2020).","journal-title":"Nat. Commun."},{"key":"33082_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s43018-020-00159-4","volume":"2","author":"L Garofano","year":"2021","unstructured":"Garofano, L. et al. Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities. Nat. Cancer 2, 141\u2013156 (2021).","journal-title":"Nat. Cancer"},{"key":"33082_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s43018-022-00510-x","volume":"4","author":"S Migliozzi","year":"2023","unstructured":"Migliozzi, S. et al. Integrative multi-omics networks identify PKC\u03b4 and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy. Nat Cancer 4, 181\u2013202 (2023).","journal-title":"Nat Cancer"},{"key":"33082_CR38","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ccell.2023.12.015","volume":"42","author":"K-H Kim","year":"2024","unstructured":"Kim, K.-H. et al. Integrated proteogenomic characterization of glioblastoma evolution. Cancer Cell 42, 358-377.e8 (2024).","journal-title":"Cancer Cell"},{"key":"33082_CR39","doi-asserted-by":"publisher","first-page":"110269","DOI":"10.1016\/j.celrep.2021.110269","volume":"38","author":"G Qin","year":"2022","unstructured":"Qin, G. et al. A functional module states framework reveals transcriptional states for drug and target prediction. Cell Rep. 38, 110269 (2022).","journal-title":"Cell Rep."},{"key":"33082_CR40","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/neuonc\/noae011","volume":"26","author":"AR Sloan","year":"2024","unstructured":"Sloan, A. R., Silver, D. J., Kint, S., Gallo, M. & Lathia, J. D. Cancer stem cell hypothesis 2.0 in glioblastoma: Where are we now and where are we going?. Neuro Oncol. 26, 785\u2013795 (2024).","journal-title":"Neuro Oncol."},{"key":"33082_CR41","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-023-06678-1","volume":"623","author":"KR Taylor","year":"2023","unstructured":"Taylor, K. R. et al. Glioma synapses recruit mechanisms of adaptive plasticity. Nature 623, 366\u2013374 (2023).","journal-title":"Nature"},{"key":"33082_CR42","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.ccell.2024.06.004","volume":"42","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Multi-scale signaling and tumor evolution in high-grade gliomas. Cancer Cell 42, 1217-1238.e19 (2024).","journal-title":"Cancer Cell"},{"key":"33082_CR43","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","volume":"573","author":"V Venkataramani","year":"2019","unstructured":"Venkataramani, V. et al. Glutamatergic synaptic input to glioma cells drives brain tumour progression. Nature 573, 532\u2013538 (2019).","journal-title":"Nature"},{"key":"33082_CR44","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","volume":"573","author":"HS Venkatesh","year":"2019","unstructured":"Venkatesh, H. S. et al. Electrical and synaptic integration of glioma into neural circuits. Nature 573, 539\u2013545 (2019).","journal-title":"Nature"},{"key":"33082_CR45","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.cell.2022.06.054","volume":"185","author":"V Venkataramani","year":"2022","unstructured":"Venkataramani, V. et al. Glioblastoma hijacks neuronal mechanisms for brain invasion. Cell 185, 2899-2917.e31 (2022).","journal-title":"Cell"},{"key":"33082_CR46","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41586-022-05520-4","volume":"613","author":"D Hausmann","year":"2023","unstructured":"Hausmann, D. et al. Autonomous rhythmic activity in glioma networks drives brain tumour growth. Nature 613, 179\u2013186 (2023).","journal-title":"Nature"},{"key":"33082_CR47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neuron.2024.10.016","volume":"113","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Potassium ion channel modulation at cancer-neural interface enhances neuronal excitability in epileptogenic glioblastoma multiforme. Neuron 113, 225-243.e10 (2025).","journal-title":"Neuron"},{"key":"33082_CR48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1158\/2159-8290.CD-23-1336","volume":"15","author":"V Mangena","year":"2025","unstructured":"Mangena, V. et al. Glioblastoma cortical organoids recapitulate cell-state heterogeneity and intercellular transfer. Cancer Discov. 15, 299\u2013315 (2025).","journal-title":"Cancer Discov."},{"key":"33082_CR49","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41467-024-45067-8","volume":"15","author":"L Hai","year":"2024","unstructured":"Hai, L. et al. A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1. Nat. Commun. 15, 968 (2024).","journal-title":"Nat. Commun."},{"key":"33082_CR50","volume-title":"A Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis","author":"P Bailey","year":"1926","unstructured":"Bailey, P. & Cushing, H. A Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis (Lippincott, 1926)."},{"key":"33082_CR51","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro Oncol. 23, 1231\u20131251 (2021).","journal-title":"Neuro Oncol."},{"key":"33082_CR52","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1038\/s41467-025-59805-z","volume":"16","author":"MG Webb","year":"2025","unstructured":"Webb, M. G. et al. Resolving spatial subclonal genomic heterogeneity of loss of heterozygosity and extrachromosomal DNA in gliomas. Nat. Commun. 16, 5290 (2025).","journal-title":"Nat. Commun."},{"key":"33082_CR53","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41568-022-00486-x","volume":"22","author":"RC Gimple","year":"2022","unstructured":"Gimple, R. C., Yang, K., Halbert, M. E., Agnihotri, S. & Rich, J. N. Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity. Nat. Rev. Cancer 22, 497\u2013514 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"33082_CR54","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41586-018-0744-4","volume":"564","author":"BA Biddy","year":"2018","unstructured":"Biddy, B. A. et al. Single-cell mapping of lineage and identity in direct reprogramming. Nature 564, 219\u2013224 (2018).","journal-title":"Nature"},{"key":"33082_CR55","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.stem.2009.05.013","volume":"4","author":"K Woolard","year":"2009","unstructured":"Woolard, K. & Fine, H. A. Glioma stem cells: Better flat than round. Cell Stem Cell 4, 466\u2013467 (2009).","journal-title":"Cell Stem Cell"},{"key":"33082_CR56","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1158\/2159-8290.CD-23-0388","volume":"14","author":"AC Bashi","year":"2024","unstructured":"Bashi, A. C. et al. Large-scale pan-cancer cell line screening identifies actionable and effective drug combinations. Cancer Discov. 14, 846\u2013865 (2024).","journal-title":"Cancer Discov."},{"key":"33082_CR57","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1016\/j.celrep.2019.02.063","volume":"26","author":"A Linkous","year":"2019","unstructured":"Linkous, A. et al. Modeling patient-derived glioblastoma with cerebral organoids. Cell Rep. 26, 3203-3211.e5 (2019).","journal-title":"Cell Rep."},{"key":"33082_CR58","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/glia.23813","volume":"68","author":"B Dundar","year":"2020","unstructured":"Dundar, B. et al. Methods for in vitro modeling of glioma invasion: Choosing tools to meet the need. Glia 68, 2173\u20132191 (2020).","journal-title":"Glia"},{"key":"33082_CR59","doi-asserted-by":"publisher","first-page":"188458","DOI":"10.1016\/j.bbcan.2020.188458","volume":"1875","author":"F Akter","year":"2021","unstructured":"Akter, F. et al. Pre-clinical tumor models of primary brain tumors: Challenges and opportunities. Biochim. Biophys. Acta BBA Rev. Cancer 1875, 188458 (2021).","journal-title":"Biochim. Biophys. Acta BBA Rev. Cancer"},{"key":"33082_CR60","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396\u2013401 (2004).","journal-title":"Nature"},{"key":"33082_CR61","doi-asserted-by":"publisher","DOI":"10.1101\/2025.09.08.674897","author":"SM Cirigliano","year":"2025","unstructured":"Cirigliano, S. M. et al. Targeting glioblastoma cell state plasticity for enhanced therapeutic efficacy. bioRxivorg https:\/\/doi.org\/10.1101\/2025.09.08.674897 (2025).","journal-title":"bioRxivorg"},{"key":"33082_CR62","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s40478-022-01420-w","volume":"10","author":"TE Richardson","year":"2022","unstructured":"Richardson, T. E. et al. Chromosomal instability in adult-type diffuse gliomas. Acta Neuropathol. Commun. 10, 115 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"33082_CR63","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/neuonc\/nor195","volume":"14","author":"H Wakimoto","year":"2012","unstructured":"Wakimoto, H. et al. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. Neuro Oncol. 14, 132\u2013144 (2012).","journal-title":"Neuro Oncol."},{"key":"33082_CR64","first-page":"7","volume":"5","author":"DE Reuss","year":"2024","unstructured":"Reuss, D. E. et al. Heterogeneity of DNA methylation profiles and copy number alterations in 10782 adult-type glioblastomas, IDH-wildtype. Free Neuropathol. 5, 7 (2024).","journal-title":"Free Neuropathol."},{"key":"33082_CR65","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1158\/2159-8290.CD-24-1555","volume":"15","author":"I Noorani","year":"2025","unstructured":"Noorani, I. et al. Extrachromosomal DNA-driven oncogene spatial heterogeneity and evolution in glioblastoma. Cancer Discov. 15, 2078\u20132095 (2025).","journal-title":"Cancer Discov."},{"key":"33082_CR66","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.cmet.2016.09.006","volume":"24","author":"DY Gui","year":"2016","unstructured":"Gui, D. Y. et al. Environment dictates dependence on mitochondrial complex I for NAD+ and aspartate production and determines cancer cell sensitivity to metformin. Cell Metab. 24, 716\u2013727 (2016).","journal-title":"Cell Metab."},{"key":"33082_CR67","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1474-9726.2006.00260.x","volume":"6","author":"KK Dhillon","year":"2007","unstructured":"Dhillon, K. K. et al. Functional role of the Werner syndrome RecQ helicase in human fibroblasts. Aging Cell 6, 53\u201361 (2007).","journal-title":"Aging Cell"},{"key":"33082_CR68","first-page":"4.2","volume":"1","author":"RR Schreck","year":"2001","unstructured":"Schreck, R. R. & Dist\u00e8che, C. M. Chromosome banding techniques. Curr. Protoc. Hum. Genet. 1, 4.2 (2001).","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"33082_CR69","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1038\/nprot.2014.170","volume":"9","author":"SR Kennedy","year":"2014","unstructured":"Kennedy, S. R. et al. Detecting ultralow-frequency mutations by duplex sequencing. Nat. Protoc. 9, 2586\u20132606 (2014).","journal-title":"Nat. Protoc."},{"key":"33082_CR70","doi-asserted-by":"publisher","first-page":"e83395","DOI":"10.7554\/eLife.83395","volume":"12","author":"M Sanchez-Contreras","year":"2023","unstructured":"Sanchez-Contreras, M. et al. The multi-tissue landscape of somatic mtdna mutations indicates tissue specific accumulation and removal in aging. Elife 12, e83395. https:\/\/doi.org\/10.7554\/eLife.83395 (2023).","journal-title":"Elife"},{"key":"33082_CR71","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature20123","volume":"539","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. Nature 539, 309\u2013313 (2016).","journal-title":"Nature"},{"key":"33082_CR72","doi-asserted-by":"publisher","first-page":"e9021","DOI":"10.15252\/msb.20199021","volume":"15","author":"M Leutert","year":"2019","unstructured":"Leutert, M., Rodr\u00edguez-Mias, R. A., Fukuda, N. K. & Vill\u00e9n, J. R2\u2013P2 rapid-robotic phosphoproteomics enables multidimensional cell signaling studies. Mol. Syst. Biol. 15, e9021 (2019).","journal-title":"Mol. Syst. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33082-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33082-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33082-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:07:21Z","timestamp":1769220441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33082-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["33082"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-33082-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,21]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3177"}}